vorasidenib
servier
['vorasidenib', 'indigo']
positive results from indigo trial presented by dr. mellinghoff at #asco today. vorasidenib compared to placebo associated with prolonged pfs and time to next treatment for patients with low grade #glioma. 
Neuro-oncologist @MayoClinicNeuro. Views are my own.